Patent ID: 11859021
Assignee: TRAINED THERAPEUTIX DISCOVERY, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  B | IPC A  B  C

Claim 29:
30. The nanobiologic composition of claim 28, wherein the phospholipid is selected from the group consisting of 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine (DMPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and further comprising a lysolipid selected from the group consisting of l-myristoyl-2-hydroxy-sn-glycero-phosphocholine (MH PC), and 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (PH PC).